Blackmores sells off Chinese medicine brands
Vitamin producer Blackmores has simplified its product offerings around the Blackmores name with the sale of its China-oriented Global Therapeutics businesses to McPherson’s Limited for $27 million. McPherson’s, a once well-known Australian manufacturer with roots dating back to 1860, has been rebuilding itself in the health, wellness and beauty products fields and takes on Global’s…
Details